Stem cell transplantation for the treatment of immunodeficiency in children: current status and hopes for the future

Expert Review of Clinical Immunology
Claire BoothPaul Veys

Abstract

Primary immunodeficiencies (PID) are rare inherited disorders affecting immune function and can be life-threatening if not treated. Haematopoietic stem cell transplantation (HSCT) offers a curative approach for many of these disorders and gene therapy is increasingly used as an alternative therapeutic strategy for patients lacking a suitable donor. Early diagnosis, improved supportive care and advances in gene and cell therapies have resulted in increased survival rates and improved quality of life. This review describes current strategies employed to improve outcomes in PID, focusing on new developments in HSCT, gene and cell therapy. We also address the challenges associated with newborn screening (NBS) programmes and novel mutations identified through improved diagnostic technology.

References

May 21, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Leo LuznikEphraim J Fuchs
Jun 19, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Fatine BenjellounMarina Cavazzana-Calvo
Aug 9, 2008·The Journal of Clinical Investigation·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Nov 11, 2008·Bone Marrow Transplantation·R RamO Shpilberg
Jan 29, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hans D OchsNeena Kapoor
Jan 31, 2009·The New England Journal of Medicine·Alessandro AiutiMaria-Grazia Roncarolo
Apr 9, 2009·Blood·Marita BosticardoMaria Grazia Roncarolo
Jun 2, 2009·The Journal of Allergy and Clinical Immunology·Mei W BakerJohn M Routes
Mar 20, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·M Louise MarkertElizabeth A McCarthy
Jul 28, 2010·The New England Journal of Medicine·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Aug 3, 2010·The Journal of Allergy and Clinical Immunology·Andrew R GenneryUNKNOWN European Society for Immunodeficiency
Nov 12, 2010·The New England Journal of Medicine·Kaan BoztugChristoph Klein
Nov 16, 2010·Current Opinion in Hematology·Reinhard A Seger
Dec 15, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karl S PeggsMark W Lowdell
Sep 20, 2011·Best Practice & Research. Clinical Haematology·Franco LocatelliLorenzo Moretta
Oct 6, 2011·Current Opinion in Pediatrics·Claire BoothAdrian J Thrasher
Nov 10, 2011·Journal of Clinical Immunology·James W VerbskyJohn M Routes
Nov 26, 2011·Pathology, Research and Practice·Nicola DanieleFrancesco Zinno
Feb 7, 2012·Blood·Juliana F FernandesUNKNOWN Eurocord and Inborn Errors Working Party of European Group for Blood and Marrow Transplantation
Mar 7, 2012·Expert Review of Clinical Immunology·Robert Chiesa, Paul Veys
Jun 14, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Niek P van TilGerard Wagemaker
Jul 18, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ulrike GerdemannAnn M Leen
May 11, 2013·The Journal of Pediatrics·Winnie IpWaseem Qasim
Jul 26, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rudolph Kirk R SchultzChristina Peters

❮ Previous
Next ❯

Citations

May 27, 2017·Blood·Mary Eapen
Aug 15, 2019·British Journal of Haematology·Maria GabelliRobert Chiesa
Oct 20, 2018·Chemical Reviews·Vern L Schramm

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Current Opinion in Allergy and Clinical Immunology
Marina CavazzanaAlain Fischer
Expert Opinion on Biological Therapy
Giorgia SantilliA J Thrasher
Current Opinion in Allergy and Clinical Immunology
Luigi D NotarangeloEvelina Mazzolari
Current Opinion in Pediatrics
Claire BoothAdrian J Thrasher
© 2022 Meta ULC. All rights reserved